ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,702Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1187

$631K Total Retail Price of All Prescriptions

Rank: 105 out of 1187

459 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 12,383 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 730 718 1 1
METOPROLOL SUCCINATE 624 592 2 11
OMEPRAZOLE 423 411 3 5
AMLODIPINE BESYLATE 352 352 4 2
FUROSEMIDE 349 349 5 8
LISINOPRIL 340 338 6 4
METFORMIN HCL 321 307 7 7
LEVOTHYROXINE SODIUM 320 320 8 3
SERTRALINE HCL 268 268 9 22
LOSARTAN POTASSIUM 218 215 10 21
METOPROLOL TARTRATE 216 216 11 10
ATORVASTATIN CALCIUM 211 210 12 6
CARVEDILOL 203 203 13 19
GLIMEPIRIDE 189 172 14 30
ZOLPIDEM TARTRATE 188 173 15 14
TAMSULOSIN HCL 182 182 16 29
ISOSORBIDE MONONITRATE ER 180 180 17 66
GABAPENTIN 168 159 18 23
TRIAMTERENE-HCTZ 155 146 19 85
CLOPIDOGREL 150 148 20 33
DIOVAN 149 149 21 17
LIPITOR 149 149 21 43
AZITHROMYCIN 126 125 23 24
ATENOLOL 126 112 23 18
TRAMADOL HCL-ACETAMINOPHEN 124 124 25 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 112 26 39
METFORMIN HCL ER 115 115 27 57
DONEPEZIL HCL 111 111 28 26
PLAVIX 110 109 29 52
SPIRONOLACTONE 108 108 30 98
MELOXICAM 103 103 31 49
LOVAZA 97 91 32 53
JANUVIA 96 91 33 34
MIRTAZAPINE 96 95 33 54
POTASSIUM CHLORIDE 94 94 35 32
WARFARIN SODIUM 93 93 36 13
LEVOFLOXACIN 93 90 36 74
KLOR-CON M20 91 91 38 93
CYMBALTA 87 87 39 60
LOSARTAN-HYDROCHLOROTHIAZIDE 86 86 40 56
FINASTERIDE 83 83 41 110
TOPROL XL 83 83 41 239
MECLIZINE HCL 81 72 43 112
NEXIUM 79 79 44 15
ALENDRONATE SODIUM 77 77 45 25
PANTOPRAZOLE SODIUM 73 71 46 42
NORTRIPTYLINE HCL 72 52 47 267
LIOTHYRONINE SODIUM 68 68 48 263
ACTOS 65 64 49 101
TRAMADOL HCL 65 65 49 28
CRESTOR 64 64 51 16
TRAZODONE HCL 64 64 51 63
LACTULOSE 61 52 53 96
SYNTHROID 59 55 54 46
COLCRYS 59 48 54 223
HYDROCHLOROTHIAZIDE 58 58 56 9
SPIRONOLACTONE-HCTZ 58 58 56 293
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 56 62
BYSTOLIC 57 53 59 116
LIDODERM 53 53 60 80
DIGOXIN 51 49 61 65
LEVOXYL 51 51 61 119
SINGULAIR 50 46 63 67
METOCLOPRAMIDE HCL 50 38 63 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.